Diabetes link with dementia to be examined

December 11, 2013

It is well known that type 2 diabetes raises the risk of dementia. The reasons for this are less clear, but one explanation could be insulin resistance in the brain, according to Malin Wennström, a researcher at Lund University's Molecular Memory Research Unit. She has received EUR 700,000 from the Swedish Research Council to investigate her theory.

"The goal is to find measureable biomarkers early in the development of dementia in diabetes patients and, in the long term, to develop drugs that can halt the process", says Malin Wennström.

Type 2 diabetes often goes hand in hand with insulin resistance, a condition that weakens the effect of insulin on body tissue, for example in muscle and fat cells. In recent years, researchers have come to understand that cells in the brain also develop insulin resistance.

The focus of Malin Wennström's research is on pericytes, a type of cell that enwraps small blood vessels in the brain. Pericytes are found throughout the body and have an important supporting function for blood vessels.

"We know that loss of pericytes is the first abnormality of the diabetic eye which can be observed clinically. Without pericytes, blood vessels become fragile and start to leak, which in time leads to poorer blood supply", says Malin Fex, a researcher at Lund University Diabetes Centre, who is also participating in the project.

One explanation as to why patients with type 2 diabetes are twice as likely to develop dementia later in life compared with non-diabetics could thus hypothetically be a loss of pericytes in the brain caused by insulin resistance.

"In one of the most common forms of dementia - vascular dementia - blood circulation in the brain is weakened, and a high proportion of Alzheimer's patients also show vascular pathology", says Malin Wennström.

The research will be carried out in three phases:

In Phase A, pericytes isolated from deceased dementia patients will be cultured and studied.

"We will stimulate the pericytes with factors that we know lead to insulin resistance, for example high levels of inflammatory signal molecules, high levels of sugar and fat, and stress hormones. We will then study the response of the pericytes by measuring changes in gene expression, protein release and levels of insulin resistance. In this way, we hope to find new biomarkers that can signal insulin resistance and other changes in the pericytes", says Malin Wennström.

In Phase B, the experiments will be transferred to laboratory animals. Insulin-resistant rodents with diabetes and rodents that have been exposed to chronic mild stress and systemic inflammation will be studied. The levels of biomarkers discovered in Phase A will be measured in the rodents's blood and cerebrospinal fluid. By simultaneously studying the brains of the rodent, the researchers can investigate whether the biomarkers reflect the biological processes induced by insulin resistance in the brain.

"The studies on cells give us insights into specific mechanisms, but to get a picture of what they look like in a complex biological system, we have to complement the studies with animal experiments."

In the final phase, Phase C, the discoveries that have been made will be tested in clinical studies. Working with Katarina Nägga, a doctor at the Memory Clinic in Malmö, samples of blood and spinal fluid from dementia patients and blood from individuals who have undergone a glucose tolerance test (a test that measures changes in the sugar metabolism that can be a sign of insulin resistance) will be analysed.

"Analysing cerebrospinal fluid is one of the few methods of studying changes in the human brain associated with disease", says Malin Wennström, adding:

"The best outcome would be if we found markers for this in the blood. We could then easily identify at an early stage, which individuals with type 2 diabetes are at increased risk of developing dementia in the future. We would then also have a concrete target for the development of treatments to halt the process."
-end-


Lund University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.